MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Patient Community Day at ECTRIMS 2025
  • Multiple Sclerosis in 2025 – Key Developments to Date
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Conferences

Home
Conferences
MS Milan 2023 Podcast

The MS Milan 2023 Podcast: Daily Episodes

MStranslate
November 16, 2023
Conferences, ECTRIMS, Podcasts
Following the success of The ECTRIMS Podcast 2022 and its subsequent episodes throughout 2023, the European Committee for Treatment and Research in Multiple Sclerosis organisation once again invited our...
ECTRIMS 2022

ECTRIMS 2022: Daily Podcasts & Summary Videos

MStranslate
November 21, 2022
Conferences, ECTRIMS, Research
The 38th meeting of the European Congress for the Treatment and Research Into Multiple Sclerosis (ECTRIMS) took place in Amsterdam, The Netherlands, between the 26th and 28th of October, 2022. The ECTRIMS...
Dr Barry Singer

ACTRIMS Forum 2022 Insights – Dr Barry Singer

MStranslate
April 4, 2022
ACTRIMS, Conferences, Research
The Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) held its annual meeting between February 24 and 26 in West Palm Beach, Florida.  Unfortunately, due to ongoing travel...
ECTRIMS Congress 2021

ECTRIMS Congress 2021: Research Insights

MStranslate
October 18, 2021
Conferences, Dr Travis Stiles, ECTRIMS, Research, Videos
Due to the ongoing challenges and restrictions of the COVID-19 pandemic, ECTRIMS Congress 2021 was once again held as a virtual conference this year.  Taking place between October 13 and 15, this meeting...
ACTRIMS Forum 2021

ACTRIMS Forum 2021 – Virtual Meeting Coverage

MStranslate
February 28, 2021
ACTRIMS, Conferences, Hormones, Research, Videos
In 2021, the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum was set to take place in Phoenix, Arizona, between February 25th to 27th.  However, due to the coronavirus...
MS Virtual 2020

MS Virtual 2020: An In-depth Interview Series

MStranslate
October 29, 2020
Conferences, MS Virtual, Q&A, Research
1 Comment
As our daily coverage of MS Virtual 2020 demonstrated, there we many fascinating presentations delivered across the three days of the conference, covering a vast spectrum of multiple sclerosis research topics...
MS Virtual 2020

MS Virtual 2020: Review of Our Day 3 Coverage

MStranslate
September 23, 2020
Conferences, MS Virtual, Research
Due to the coronavirus pandemic, this year’s joint ACTRIMS-ECTRIMS Congress, which was meant to take place in Washington DC, became MS Virtual 2020, a conference conducted entirely online. We are pleased...
MS Virtual 2020

MS Virtual 2020: Review of Our Day 2 Coverage

MStranslate
September 18, 2020
Conferences, MS Virtual, Research
1 Comment
Due to the coronavirus pandemic, this year’s joint ACTRIMS-ECTRIMS Congress, which was meant to take place in Washington DC, became MS Virtual 2020, a conference conducted entirely online. We are pleased...
MS Virtual 2020

MS Virtual 2020: Review of Our Day 1 Coverage

MStranslate
September 14, 2020
Conferences, MS Virtual, Research
2 Comments
Due to the coronavirus pandemic, this year's joint ACTRIMS-ECTRIMS Congress, which was meant to take place in Washington DC, became MS Virtual 2020, a conference conducted entirely online. We are pleased to...
MS Virtual 2020

MS Virtual 2020: Looking Forward to the Week Ahead

MStranslate
September 8, 2020
Conferences, MS Virtual, Research
1 Comment
The world’s largest multiple sclerosis conference begins this week.  ECTRIMS (the European Committee for Treatment and Research In Multiple Sclerosis) brings together researchers and clinicians from around...
  1. 1
  2. 2
  3. 3

Recent Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Recent Comments

  • FDA Decision On Tolebrutinib - MStranslate on Multiple Sclerosis in 2025 – Key Developments to Date
  • Treatment With Gut Bacteria Shows Benefits In New Study on Gut Bacteria in People Living with RRMS
  • Community Q&A: COVID-19 Vaccines & Multiple Sclerosis on Community Q&A: The Blood-Brain Barrier
  • Community Q&A: Why Don't We Have A Multiple Sclerosis Cure? on Community Q&A: COVID-19 Vaccines & MS
  • Tim Little on FAKE NEWS ALERT: COVID Vaccines & MS

Calendar

March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
« Jan    

Archives

Categories

Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.